COX5A Plays a Vital Role in Memory Impairment Associated With Brain Aging via the BDNF/ERK1/2 Signaling Pathway

Yan-Bin Xiyang,Ruan Liu,Xu-Yang Wang,Shan Li,Ya Zhao,Bing-Tuan Lu,Zhi-Cheng Xiao,Lian-Feng Zhang,Ting-Hua Wang,Jie Zhang
DOI: https://doi.org/10.3389/fnagi.2020.00215
IF: 4.8
2020-07-10
Frontiers in Aging Neuroscience
Abstract:Cytochrome c oxidase subunit Va (COX5A) is involved in maintaining normal mitochondrial function. However, little is known on the role of COX5A in the development and progress of Alzheimer's disease (<a href="#B100">Martinez-Losa et al., 2018</a>). In this study, we established and characterized the genomic profiles of genes expressed in the hippocampus of Senescence-Accelerated Mouse-prone 8 (SAMP8) mice, and revealed differential expression of COX5A among 12-month-aged SAMP8 mice and 2-month-aged SAMP8 mice. Newly established transgenic mice with systemic COX5A overexpression (51% increase) resulted in the improvement of spatial recognition memory and hippocampal synaptic plasticity, recovery of hippocampal CA1 dendrites, and activation of the BDNF/ERK1/2 signaling pathway <i>in vivo</i>. Moreover, mice with both COX5A overexpression and BDNF knockdown showed a poor recovery in spatial recognition memory as well as a decrease in spine density and branching of dendrites in CA1, when compared to mice that only overexpressed COX5A. <i>In vitro</i> studies supported that COX5A affected neuronal growth <i>via</i> BDNF. In summary, this study was the first to show that COX5A in the hippocampus plays a vital role in aging-related cognitive deterioration <i>via</i> BDNF/ERK1/2 regulation, and suggested that COX5A may be a potential target for anti-senescence drugs.
neurosciences,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?